First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes

Diabetologia

Volumn 45, Issue 12, 2002, Pages 1639-1648

  Keskinen, Paivi ^a,b   Korhonen, S ^c   Kupila, A ^a   Veijola, R ^c   Erkkila, S ^a   Savolainen, H ^a   Arvilommi, P ^a   Simell, T ^a   Ilonen, J ^a   Knip, M ^b,d   Simell, O ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoantibodies; HLA risk markers; Insulin secretion; Prediabetic state; Type I diabetes

Indexed keywords

AUTOANTIBODY; INSULIN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQB1 ANTIGEN; IA ANTIGEN;

ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOLOGY; IMPAIRED GLUCOSE TOLERANCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; AUTOIMMUNITY; DISEASE COURSE; FOLLOW UP; GENETIC RISK; INSULIN RESPONSE; INTRAVENOUS GLUCOSE TOLERANCE TEST; NORMAL HUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCREENING TEST; SEROCONVERSION;

AUTOANTIBODIES; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE SUSCEPTIBILITY; DOUBLE-BLIND METHOD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; HUMANS; INFANT; INSULIN; INSULIN ANTIBODIES; MALE; PREDIABETIC STATE; PROGNOSIS;

EID: 0036460571     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0981-8     Document Type: Article

References (34)

1. Daniel S, Noda M, Straub SG, Sharp GW “1999” Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. Diabetes 48:1686-1690
2. Bingley PJ, Colman P, Eisenbarth GS et al. “1992” Standardization of IVGTT to predict IDDM. Diabetes Care 15:1313-1316
3. Bingley PJ “1996” Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: The ICARUS data set. Islet Cell Antibody Registers Users Study. Diabetes 45:1720-1728
4. Ganda OP, Srikanta S, Brink SJ et al. “1984” Differential sensitivity to beta-cell secretagogues in "early" type I diabetes mellitus. Diabetes 33:516-521
5. Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS “1984” Pre-type 1 diabetes. Linear loss of beta cell response to intravenous glucose. Diabetes 33:717-720
6. Vialettes B, Mattei-Zevaco C, Badier C, Ramahandridona G, Lassman-Vague V, Vague P “1988” Low acute insulin response to intravenous glucose. A sensitive but non-specific marker of early stages of Type I “insulin-dependent” diabetes. Diabetologia 31:592-596
7. Vardi P, Crisa L, Jackson RA “1991” Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of Type I “insulin-dependent” diabetic patients. Diabetologia 34:93-102
8. Herskowitz-Dumont R, Wolfsdorf JI, Jackson RA, Eisenbarth GS “1993” Distinction between transient hyperglycemia and early insulin-dependent diabetes mellitus in childhood: A prospective study of incidence and prognostic factors. J Pediatr 123:347-354
9. Greenbaum CJ, Sears KL, Kahn SE, Palmer JP “1999” Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: Follow-up of the Seattle Family Study. Diabetes 48:170-175
10. Bardet S, Pasqual C, Maugendre D, Remy JP, Charbonnel B, Sai P “1989” Inter and intra individual variability of acute insulin response during intravenous glucose tolerance tests. Diabetes Metab 15:224-232
11. + relatives of patients with type 1 diabetes. Diabetes Care 13:111-118
12. Robert J-J, Deschamps I, Chevenne D, Roger M, Mogenet A, Boitard C “1991” Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type 1 diabetes in 220 juvenile first-degree relatives of diabetic patients. Diabetes Care 14:718-723
13. Veijola R, Vahasalo P, Tuomilehto-Wolf E et al. “1995” Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Diabetes 44:1021-1028
14. Chase HP, Cuthbertson DD, Dolan LM et al. “2001” First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 138:244-249
15. Hahl J, Simell T, Ilonen J, Knip M, Simell O “1998” Costs of predicting IDDM. Diabetologia 41:79-85
16. Kupila A, Muona P, Simell T et al. “2001” Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohort. Diabetologia 44:290-297
17. Nejentsev S, Sjoroos M, Soukka T et al. “1999” Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: Selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 16:985-992
18. Sjoroos M, Iitia A, Ilonen J, Reijonen H, Lovgren T “1995” Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18:870-877
19. Knip M, Karjalainen J, Åkerblom HK, and the Childhood Diabetes in Finland Study Group “1998” Islet cell anti-bodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. Diabetes Care 21:1670-1673
20. Bottazzo GF, Florin-Christensen A, Doniach D “1974” Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet ii:1279-1283
21. Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EAM “1997” A novel micro-assay for insulin autoanti-bodies. J Autoimmun 10:473-478
22. Ronkainen M, Hamalainen A-M, Koskela P, Åkerblom HK, Knip M “2001” Pregnancy induces nonimmunoglobulin insulin-binding activity in both maternal and cord blood serum. Clin Exp Immunol 124:190-196
23. Verge CF, Stenger D, Bonifacio E et al. “1998” Combined use of autoantibodies “IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell anti-bodies” in type 1 diabetes: Combinatorial islet antibody workshop. Diabetes 47:1857-1866
24. Savola K, Sabbah E, Kulmala P, Vahasalo P, Ilonen J, Knip M “1998” Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Diabetologia 41:1293-1297
25. Savola K, Bonifacio E, Sabbah E et al. “1998” IA-2 anti-bodies - A sensitive marker of IDDM with clinical onset in children and adolescents. Diabetologia 41:424-429
26. Riley WJ, Maclaren NK, Krischer J et al. “1990” A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323:1167-1172
27. Carel JC, Boitard C, Bougneres PF “1993” Decreased insulin response to glucose in islet cell antibody-negative siblings of type 1 diabetic children. J Clin Invest 92:509-513
28. Maclaren N, Lan M, Coutant R et al. “1999” Only multiple autoantibodies to islet cells “ICA”, insulin, GAD65, IA-2 and IA-2β predict immune-mediated “type 1” diabetes in relatives. J Autoimmun 12:279-287
29. Kulmala P, Rahko J, Savola K et al. “2000” Stability of autoantibodies and their relation to genetic and metabolic markers of Type 1 diabetes in initially unaffected schoolchildren. Diabetologia 43:457-464
30. Allen HF, Jeffers BW, Klingensmith GJ, Chase HP “1993” First-phase insulin release in normal children. J Pediatr 123:733-738
31. Lorini R, Vanelli M, and the Prediabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology “SIEDP” “1996” Normal values of first-phase insulin response to intravenous glucose in healthy Italian children and adolescents. J Pediatr Endocrinol Metab 9:163-167
32. Leslie RD, Elliott RB “1994” Early environmental events as a cause of IDDM. Evidence and implications. Diabetes 43:843-850
33. Ziegler AG, Hummel M, Schenker M, Bonifacio E “1999” Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB Study. Diabetes 48:460-468
34. Kupila A, Keskinen P, Simell T et al. “2002” Genetic risk determines the emergence of diabetes-associated autoanti-bodies in young children. Diabetes 51:646-651